Secondary interstitial lung disease specific to childhood associated with a systemic vasculitis

Secondary interstitial lung disease specific to childhood associated with systemic vasculitis is a rare pediatric pulmonary condition classified under the broader category of childhood interstitial lung diseases (chILD). In this disorder, inflammation of blood vessels (systemic vasculitis) — such as may occur in granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), or other childhood vasculitides — leads to secondary damage and remodeling of the lung interstitium. The interstitium is the tissue and space surrounding the air sacs of the lungs, and when it becomes inflamed or scarred, gas exchange is impaired. Key symptoms include chronic cough, progressive shortness of breath (dyspnea), exercise intolerance, tachypnea (rapid breathing), and in some cases hemoptysis (coughing up blood) or recurrent respiratory infections. Because the underlying cause is a systemic vasculitis, children may also present with constitutional symptoms such as fever, fatigue, weight loss, skin rashes, joint pain, and involvement of other organs including the kidneys, sinuses, and eyes. Chest imaging typically reveals diffuse interstitial infiltrates, ground-glass opacities, or nodular lesions, and pulmonary function testing may show a restrictive or mixed pattern. Treatment is directed at the underlying systemic vasculitis and typically involves immunosuppressive therapy. First-line treatment often includes systemic corticosteroids combined with steroid-sparing agents such as cyclophosphamide, methotrexate, azathioprine, or rituximab, depending on the specific vasculitis subtype and disease severity. Supportive respiratory care, including supplemental oxygen and pulmonary rehabilitation, may also be necessary. Early diagnosis and aggressive management of the vasculitis are critical to preventing irreversible lung fibrosis and preserving pulmonary function. Long-term follow-up with a multidisciplinary team including pediatric pulmonologists and rheumatologists is essential.

Common questions about Secondary interstitial lung disease specific to childhood associated with a systemic vasculitis